Clinical Trials in New York

Showing 4641-4660 of 22,668 trials

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

NCT05359562

Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for obsessive compulsive disorder (OCD). This study will examine the effect of delivering EX/RP to women during different phases in their menstrual cycle to determine the effects of hormones on the fear extinction network and on their OCD symptoms.

OCD

University of Pennsylvania120 participantsStarted Jun 2022

New York, New York, United States • Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

NCT06975371

This study aims to assess the treatment patterns and real-world outcomes of HR+/HER- metastatic breast cancer patients who have progressed on 1L ET + CDK4/6i and started a second line (2L) treatment within a real-world cohort in the United States Flatiron Health Database.

Advanced/Metastatic HER2-negative Breast Cancer

Daiichi Sankyo1,415 participantsStarted Apr 2025

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03776812

This is a Phase 2, open-label, randomized, 3-arm study to evaluate progression-free survival (PFS) in patients with recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer treated with intermittent or continuous regimens of relacorilant in combination with nab-paclitaxel compared with patients treated with nab-paclitaxel alone.

Recurrent Ovarian CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma

Corcept Therapeutics178 participantsStarted Apr 2019

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Denver, Colorado, United States +21 more locations

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Find Trials by Condition in New York

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments

ESP Block in MIS Lumbar Spine Surgery

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

Improving Outcomes Assessment in Chronic GVHD

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers

Acquired Dyslexia Modeling and Treatment

VItamin C in Thermal injuRY: The VICToRY Trial

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection